Abstract
Recent studies have shown the relevance of anxiety and depression on the prognosis and outcome of COPD patients, which lead to an increased risk of exacerbations and hospitalisations, a high risk of mortality, greater functional impairment, poorer quality of life, poor adherence to rehabilitation and respiratory care, better use of health resources and increased frequency of COPD symptoms. Their high prevalence is probably due to lack of knowledge, inadequate assessment and undertreatment of psychiatric symptoms and/or disorders.
It is, therefore, necessary to assess the presence of anxiety and/or depression in COPD patients in details and subsequent treatment to suitably control their psychiatric disorder as this will result in better control and progression of COPD.
Keywords: COPD, anxiety, depression, outcomes, exacerbations, mortality, symptoms, undertreatment.
Current Respiratory Medicine Reviews
Title:Relevance of Anxiety and Depression in Chronic Obstructive Pulmonary Disease (COPD)
Volume: 10 Issue: 4
Author(s): Francisco Javier Callejas Gonzalez, Marta Genoves Crespo, Javier Cruz Ruiz and Pedro Juan Tarraga Lopez
Affiliation:
Keywords: COPD, anxiety, depression, outcomes, exacerbations, mortality, symptoms, undertreatment.
Abstract: Recent studies have shown the relevance of anxiety and depression on the prognosis and outcome of COPD patients, which lead to an increased risk of exacerbations and hospitalisations, a high risk of mortality, greater functional impairment, poorer quality of life, poor adherence to rehabilitation and respiratory care, better use of health resources and increased frequency of COPD symptoms. Their high prevalence is probably due to lack of knowledge, inadequate assessment and undertreatment of psychiatric symptoms and/or disorders.
It is, therefore, necessary to assess the presence of anxiety and/or depression in COPD patients in details and subsequent treatment to suitably control their psychiatric disorder as this will result in better control and progression of COPD.
Export Options
About this article
Cite this article as:
Callejas Gonzalez Javier Francisco, Crespo Genoves Marta, Ruiz Cruz Javier and Tarraga Lopez Juan Pedro, Relevance of Anxiety and Depression in Chronic Obstructive Pulmonary Disease (COPD), Current Respiratory Medicine Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/1573398X11666150427222528
DOI https://dx.doi.org/10.2174/1573398X11666150427222528 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
NAD(P) Biosynthesis Enzymes as Potential Targets for Selective Drug Design
Current Medicinal Chemistry Stem Cell Ageing and Apoptosis
Current Pharmaceutical Design Role of Vascular Progenitor Cells in Cardiovascular Disease
Current Pharmaceutical Design Effects of Tea Catechins on Inflammation-Related Cardiovascular Diseases
Current Immunology Reviews (Discontinued) Effects of the Antidiabetic Drugs on the Age-Related Atrophy and Sarcopenia Associated with Diabetes Type II.
Current Diabetes Reviews Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective
CNS & Neurological Disorders - Drug Targets From Nature to Drug Discovery: The Indole Scaffold as a ‘Privileged Structure’
Mini-Reviews in Medicinal Chemistry Vascular Calcification in Chronic Kidney Disease: Role of Disordered Mineral Metabolism
Current Pharmaceutical Design Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets
Current Drug Targets New Challenges for ACE-Inhibitors in Vascular Diseases
Drug Design Reviews - Online (Discontinued) Clinical Experience with the Use of Angiotensin Receptor Blockers in Patients with Cardiovascular, Cerebrovascular and Renal Diseases
Current Clinical Pharmacology Polymeric Carriers for Gene Delivery: Chitosan and Poly(amidoamine) Dendrimers
Current Pharmaceutical Design Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?
Current Hypertension Reviews Treatment of Hypertension in Chronic Kidney Disease: Does one Size Fit All? A Narrative Review from a Nephrologist’s Perspective
Current Hypertension Reviews Ovulation, Implantation and Placentation in Females with Obesity and Metabolic Disorders: Life in the Balance
Endocrine, Metabolic & Immune Disorders - Drug Targets Wharton’s Jelly or Bone Marrow Mesenchymal Stromal Cells Improve Cardiac Function Following Myocardial Infarction for More Than 32 Weeks in a Rat Model: A Preliminary Report
Current Stem Cell Research & Therapy PET Imaging to Monitor Cancer Therapy
Current Pharmaceutical Biotechnology Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as a New Lead for Treating Breast and Ovarian Cancer
Current Drug Targets New Viral Infection COVID-19: Current Status, Challenges and Possible Treatments
Letters in Drug Design & Discovery